Are you Dr. Bedrosian?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
26 Landsdowne Street
Cambridge, MA 02139Phone+1 617-494-0400Fax+1 617-494-8144
Summary
- Dr. Camille Bedrosian, MD is an oncologist in Cambridge, Massachusetts. She is currently licensed to practice medicine in Massachusetts and North Carolina.
Education & Training
- Harvard Medical SchoolClass of 1983
Certifications & Licensure
- MA State Medical License 1998 - 2026
- NC State Medical License 1987 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 12 citationsBuilding the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding d...Diane Nugent, Suchitra S Acharya, Kimberly J Baumann, Camille Bedrosian, Rebecca Bialas
Expert Review of Hematology. 2023-03-01 - 1 citationsClinical trial data available for UX001, aceneuramic acid extended-releaseCamille L. Bedrosian
Journal of the Neurological Sciences. 2020-04-15 - 59 citationsPhase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: blockade of the immune checkpoint CD200Daruka Mahadevan, Mark C. Lanasa, Charles M. Farber, Manjari Pandey, Maria Whelden
Journal for Immunotherapy of Cancer. 2019-08-23
Press Mentions
- New Research Aims to Address Unmet Needs Following Weight Loss SurgeriesMarch 4th, 2025
- Amylyx Touts ‘Encouraging’ Phase 2 Alzheimer’s Trial DataAugust 15th, 2024
- Amylyx Pharmaceuticals Announces Publication of Data Showing the Encouraging Effects of AMX0035 on Cerebrospinal Fluid Biomarkers of Core Alzheimer’s Disease Pathology and NeurodegenerationAugust 12th, 2024
- Join now to see all